Collegium Pharmaceutical, Inc. (COLL)
Develops prescription pain management medicines including opioids and abuse-deterrent formulations.
$35.90+0.01%Healthcare
StockGlow Score
Leaning Bullish
BearishBullish
1 year ago+19.4%
The outlook
COLL trades at $35.90 with analyst consensus leaning bullish; the average price target sits roughly 49% above the current price. The stock sits in the lower third of its 52-week range and shows mixed momentum against its moving averages, with a trailing P/E of 17.4.
What’s behind the score
Analyst consensusBuy — 1.8 avg of 5 analysts
Price trendMixed vs its moving averages
52-week range31% of the way from its 52-week low to high
Price targetAvg target +49% vs current price
Analyst price target
~12-month · 5 analysts$53.60average target+49.3% vs now
Now $35.90
Low $45.00High $60.00
Published targets from Wall Street analysts (public data) — what analysts expect over roughly a year. This is not a StockGlow forecast and not a recommendation. Analyst targets are frequently wrong.
Market cap
$1.16B
52-wk high
$50.79
52-wk low
$29.19
50-day avg
$34.64
200-day avg
$39.26
Trailing P/E
17.4